Medical Health & Life Science Research News

Research delivers insight into the Global community acquired pneumonia pipeline therapeutics market review H2 2017

Research delivers insight into the Global community acquired pneumonia pipeline therapeutics market review H2 2017

The Community Acquired Pneumonia pipeline guide reviews latest news related to pipeline therapeutics for Community Acquired Pneumonia (Infectious Disease)

- Agency -.

The Community-Acquired Pneumonia Pipeline report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Key players of H2 Community-Acquired Pneumonia Pipeline 2017 are Aridis Pharmaceuticals LLC,
Biotest AG, InflaRx GmbH, ioGenetics Inc, Kyorin Pharmaceutical Co Ltd, Melinta Therapeutics Inc,
Merck & Co Inc, Nabriva Therapeutics AG, Paratek Pharmaceuticals Inc, TaiGen Biotechnology Co Ltd, Takeda Pharmaceutical Company Ltd, Tetraphase Pharmaceuticals Inc, TiGenix NV, Wockhardt Ltd

Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a hospital or long-term care facility. Symptoms include cough, fever, shaking chills, confusion, headache and loss of appetite.

Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis and diabetes mellitus.

- Agency -.

Treatment includes antibiotics and healthy lifestyle.

Get Community-Acquired Pneumonia Pipeline Review Report [email protected] www.reportsnreports.com/contacts/d…aspx?name=1132636 .

Community-Acquired Pneumonia Pipeline H2 2017- Drug Profiles : BT-086, CAL-02, ceftaroline fosamil, Cx-611, DBAF-301, delafloxacin meglumine, IFX-1, lascufloxacin, lefamulin acetate, nafithromycin, nemonoxacin, omadacycline tosylate, PneumoMab, solithromycin, tosatoxumab, TP-271.

Community-Acquired Pneumonia Pipeline H2 2017, provides comprehensive information on the therapeutics under development for Community-Acquired Pneumonia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Access Complete Report On Community-Acquired Pneumonia Pipeline Review H2 2017: www.reportsnreports.com/purchase.aspx?name=1125836

The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

The report provides a snapshot of the global therapeutic landscape of Community-Acquired Pneumonia. The report reviews pipeline therapeutics for Community-Acquired Pneumonia by companies and universities/research institutes based on information derived from company and industry-specific sources.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Community-Acquired Pneumonia therapeutics and enlists all their major and minor projects. The report assesses Community-Acquired Pneumonia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Community-Acquired Pneumonia

List of Figures
Number of Products under Development for Community Acquired Pneumonia, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.